GBA1 and Parkinson disease: Specifically, mutations causing more significant reduction in glucocerebrosidase enzymatic activity and more severe, neuronopathic Gaucher consistently result not only in greater PD penetrance (among heterozygous carriers) but also in decreased age at onset, more rapid decline, and increased dementia risk (103, 104).